Cannabinoids in eating disorders and obesity (Q36977777)

17 August 2017

1 reference

title

Cannabinoids in eating disorders and obesity (English)

1 reference

17 August 2017

0 references

1 reference

Francisco Arias Horcajadas

series ordinal

1

1 reference

17 August 2017

7 July 2007

1 reference

17 August 2017

Molecular Neurobiology

1 reference

17 August 2017

36

1 reference

17 August 2017

1

1 reference

17 August 2017

113-128

1 reference

https://scigraph.springernature.com/pub.10.1007/s12035-007-0018-x

17 August 2017

0 references

cites work

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

1 reference

https://api.crossref.org/works/10.1007%2FS12035-007-0018-X

Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-007-0018-X

Cannabinoids suppress synaptic input to neurones of the rat dorsal motor nucleus of the vagus nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-007-0018-X

Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-007-0018-X

Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-007-0018-X

Effect of cannabinoids on neural transmission in rat gastric fundus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-007-0018-X

Gonadotropin response to clomiphene and plasma leptin levels in weight recovered but amenorrhoeic patients with anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-007-0018-X

Meta-analysis: pharmacologic treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-007-0018-X

Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol

21 January 2018

1 reference

12 December 2020

Leptin functioning in eating disorders

1 reference

12 December 2020

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

1 reference

12 December 2020

Marijuana Intoxication : Common Experiences

1 reference

12 December 2020

Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole--LH 21.

1 reference

12 December 2020

Effects of SR141716A on ethanol and sucrose self-administration

1 reference

12 December 2020

1 reference

12 December 2020

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

1 reference

12 December 2020

Cannabinoid receptor signaling directly inhibits thermogenesis and alters expression of adiponectin and visfatin

1 reference

12 December 2020

Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems

1 reference

12 December 2020

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

1 reference

12 December 2020

SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset

1 reference

12 December 2020

Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake

1 reference

12 December 2020

Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study

1 reference

12 December 2020

The endocannabinoid system and the treatment of obesity

1 reference

12 December 2020

Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form of anorexia nervosa and bulimia nervosa.

1 reference

12 December 2020

Food for thought: endocannabinoid modulation of lipogenesis

1 reference

12 December 2020

Circulating ghrelin is decreased in non-obese and obese women with binge eating disorder as well as in obese non-binge eating women, but not in patients with bulimia nervosa.

1 reference

12 December 2020

Effects of marihuana use on body weight and caloric intake in humans

1 reference

12 December 2020

Possible genomic imprinting of three human obesity-related genetic loci

1 reference

12 December 2020

Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin.

1 reference

12 December 2020

Cannabinoid receptor binding did not vary in several hypothalamic nuclei after hypothalamic deafferentation.

1 reference

12 December 2020

Evidence for a susceptibility gene for anorexia nervosa on chromosome 1.

1 reference

12 December 2020

Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002.

1 reference

12 December 2020

Localization of a "feeding center" in the hypothalamus of the rat.

1 reference

12 December 2020

Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia

1 reference

12 December 2020

Endocannabinoids and food consumption: comparisons with benzodiazepine and opioid palatability-dependent appetite

1 reference

12 December 2020

Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use.

1 reference

12 December 2020

CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity

1 reference

12 December 2020

Genetics of human obesity

1 reference

12 December 2020

Evidence for an interaction between CB1 cannabinoid and oxytocin receptors in food and water intake

1 reference

12 December 2020

Dietary fat and obesity: a review of animal, clinical and epidemiological studies

1 reference

12 December 2020

Behavioral mechanisms underlying inhibition of food-maintained responding by the cannabinoid receptor antagonist/inverse agonist SR141716A.

1 reference

12 December 2020

Endocannabinoids and the control of energy balance

1 reference

12 December 2020

The cannabinoid CB1 receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelin.

1 reference

12 December 2020

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

1 reference

12 December 2020

Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice

1 reference

12 December 2020

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells

1 reference

12 December 2020

Introduction to the reviews on peptides and the control of food intake and body weight

1 reference

12 December 2020

Observational analysis of feeding induced by Delta9-THC and anandamide

1 reference

12 December 2020

Rimonabant--a selective CB1 antagonist

1 reference

12 December 2020

Cannabinoids, opioids and eating behavior: the molecular face of hedonism?

1 reference

12 December 2020

The endocannabinoid system as a target for the treatment of visceral obesity and metabolic syndrome

1 reference

12 December 2020

Trick or treat from food endocannabinoids?

1 reference

12 December 2020

Delta9-tetrahydrocannabinol stimulates palatable food intake in Lewis rats: effects of peripheral and central administration.

1 reference

12 December 2020

The cannabinoid CB1 receptor antagonist SR141716A reduces appetitive and consummatory responses for food.

1 reference

12 December 2020

Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism.

1 reference

12 December 2020

The role of CB1 receptors in sweet versus fat reinforcement: effect of CB1 receptor deletion, CB1 receptor antagonism (SR141716A) and CB1 receptor agonism (CP-55940).

1 reference

12 December 2020

Thoughts for food: brain mechanisms and peripheral energy balance

1 reference

12 December 2020

A missense mutation in human fatty acid amide hydrolase associated with problem drug use.

1 reference

12 December 2020

Potential modulation of plasma ghrelin and glucagon-like peptide-1 by anorexigenic cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide

1 reference

12 December 2020

Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice

1 reference

12 December 2020

Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats.

1 reference

12 December 2020

The emerging role of the endocannabinoid system in endocrine regulation and energy balance

1 reference

12 December 2020

Food reward: brain substrates of wanting and liking

1 reference

12 December 2020

Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia

1 reference

12 December 2020

The functional neuroanatomy of brain cannabinoid receptors.

1 reference

12 December 2020

Fighting obesity and associated risk factors by antagonising cannabinoid type 1 receptors

1 reference

12 December 2020

The enzymatic inactivation of the fatty acid amide class of signaling lipids

1 reference

12 December 2020

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

1 reference

12 December 2020

Blockade by the cannabinoid CB1 receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior

1 reference

12 December 2020

Endocannabinoids in the regulation of appetite and body weight

1 reference

12 December 2020

Genetic analysis of bulimia nervosa: methods and sample description.

1 reference

12 December 2020

Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease.

1 reference

12 December 2020

Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats

1 reference

12 December 2020

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

1 reference

12 December 2020

Association study of cannabinoid receptor gene (CNR1) alleles and anorexia nervosa: differences between restricting and binging/purging subtypes

1 reference

12 December 2020

Endocannabinoid synthesis and degradation, and their regulation in the framework of energy balance.

1 reference

12 December 2020

Cannabinoids and appetite stimulation

1 reference

12 December 2020

Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit

1 reference

12 December 2020

Association between cannabinoid type-1 receptor polymorphism and body mass index in a southern Italian population

1 reference

12 December 2020

CB1 cannabinoid receptor-mediated modulation of food intake in mice

1 reference

12 December 2020

Hunger and appetite after single doses of marihuana, alcohol, and dextroamphetamine

1 reference

12 December 2020

Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after delta(9)-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716.

1 reference

12 December 2020

Marijuana and cannabinoid regulation of brain reward circuits

1 reference

12 December 2020

Leptin-regulated endocannabinoids are involved in maintaining food intake

1 reference

12 December 2020

The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats

1 reference

12 December 2020

Elevated peptide YY levels in adolescent girls with anorexia nervosa

1 reference

12 December 2020

Cannabinoid receptor gene (CNR1): association with i.v. drug use.

1 reference

12 December 2020

Consumption of high carbohydrate, high fat, and normal chow is equally suppressed by a cannabinoid receptor antagonist in non-deprived rats

1 reference

12 December 2020

Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase.

1 reference

12 December 2020

Hyperphagia in pre-fed rats following oral delta9-THC.

1 reference

12 December 2020

Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH).

1 reference

12 December 2020

Multiple neural systems controlling food intake and body weight

1 reference

12 December 2020

Effects of marihuana on the solution of anagrams, memory and appetite.

1 reference

12 December 2020

Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men.

1 reference

12 December 2020

Evidence for an interaction between CB1 cannabinoid and melanocortin MCR-4 receptors in regulating food intake.

1 reference

12 December 2020

Review of the validity and significance of cannabis withdrawal syndrome

1 reference

12 December 2020

The cannabinoid CB1 antagonist AM 251 produces food avoidance and behaviors associated with nausea but does not impair feeding efficiency in rats.

1 reference

12 December 2020

The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Delta9-tetrahydrocannabinol

1 reference

12 December 2020

Genetic and environmental contributions to obesity and binge eating

1 reference

12 December 2020

Cocaine- and amphetamine-related transcript is involved in the orexigenic effect of endogenous anandamide

1 reference

12 December 2020

Hypersensitization of the Orexin 1 receptor by the CB1 receptor: evidence for cross-talk blocked by the specific CB1 antagonist, SR141716

1 reference

12 December 2020

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

1 reference

12 December 2020

Plasma leptin, neuropeptide Y (NPY) and galanin concentrations in bulimia nervosa and in anorexia nervosa

1 reference

12 December 2020

Endocannabinoids and the gastrointestinal tract

1 reference

12 December 2020

Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity

1 reference

12 December 2020

Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa

1 reference

12 December 2020

Gastric antisecretory role and immunohistochemical localization of cannabinoid receptors in the rat stomach

1 reference

12 December 2020

Cannabinoid agonist, CP 55,940, facilitates intake of palatable foods when injected into the hindbrain

1 reference

12 December 2020

The genetics of human obesity

1 reference

12 December 2020

Twin study of genetic and environmental influences on adult body size, shape and composition

1 reference

12 December 2020

Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats

1 reference

12 December 2020

The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes

1 reference

12 December 2020

Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and mood

1 reference

12 December 2020

The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance

1 reference

12 December 2020

Investigation of peptide YY and ghrelin responses to a test meal in bulimia nervosa.

1 reference

12 December 2020

Effects of the endocannabinoid noladin ether on body weight, food consumption, locomotor activity, and cognitive index in mice

1 reference

12 December 2020

Endocannabinoids and energy metabolism.

1 reference

12 December 2020

Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study

1 reference

12 December 2020

Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors.

1 reference

12 December 2020

A double-blind trial of delta 9-tetrahydrocannabinol in primary anorexia nervosa

1 reference

12 December 2020

Refinement of behavioural traits in animals for the genetic dissection of eating disorders

1 reference

12 December 2020

Central nervous system control of food intake and body weight

1 reference

12 December 2020

Lack of association between polymorphisms in cannabinoid receptor gene (CNR1) and fatty acid amide hydroxylase gene (FAAH) and eating disorders in a preliminary study.

1 reference

12 December 2020

Activation of the peripheral endocannabinoid system in human obesity

1 reference

12 December 2020

A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.

1 reference

12 December 2020

Very low doses of delta 8-THC increase food consumption and alter neurotransmitter levels following weight loss

1 reference

12 December 2020

Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice.

1 reference

12 December 2020

Pharmacology of appetite suppression.

1 reference

12 December 2020

Abstinence symptoms following oral THC administration to humans.

1 reference

12 December 2020

Behavioral analysis of marijuana effects on food intake in humans

1 reference

12 December 2020

Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory

1 reference

12 December 2020

Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors

1 reference

12 December 2020

Appetite suppression and weight loss after the cannabinoid antagonist SR 141716.

1 reference

12 December 2020

Coexpression of the cannabinoid receptor type 1 with the corticotropin-releasing hormone receptor type 1 in distinct regions of the adult mouse forebrain.

1 reference

12 December 2020

Abstinence symptoms following smoked marijuana in humans.

1 reference

12 December 2020

Brain regulation of food intake and appetite: molecules and networks

1 reference

12 December 2020

Genome-Wide Linkage Scan for the Metabolic Syndrome in the HERITAGE Family Study

1 reference

12 December 2020

Lack of tolerance to the suppressing effect of rimonabant on chocolate intake in rats

1 reference

12 December 2020

Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding.

1 reference

12 December 2020

Endocannabinoid signaling system and brain reward: emphasis on dopamine

1 reference

12 December 2020

Cannabinoid (CB)1 receptor antagonist, AM 251, causes a sustained reduction of daily food intake in the rat.

1 reference

12 December 2020

Oleamide and anandamide effects on food intake and sexual behavior of rats

1 reference

12 December 2020

Genes, lifestyles and obesity

1 reference

12 December 2020

10.1007/S12035-007-0018-X

Identifiers

DOI

1 reference

release_fpvz3vlpxvagderj2lnxcmn4vi

17 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fpvz3vlpxvagderj2lnxcmn4vi

24 November 2022

mapped directly with Wikidata item

PubMed ID

17952656

1 reference

PubMed ID

17952656